Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 30Thoracic 4Gynecologic 4Gastrointestinal 4Genitourinary 3Head & Neck 2Endocrine 2Sarcoma 1CNS 1

Conditions

Sarcoma 6Breast Neoplasms 5Ovarian Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Triple Negative Breast Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Osteosarcoma 2Neoplasms 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma, Synovial 1Recurrence 1Pathologic Complete Response 1Neoplasm Metastasis 1Lung Neoplasms 1Hemangiosarcoma 1Esophageal Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Carcinoma, Ovarian Epithelial 1Breast Neoplasms, Male 1

Interventions

Radiotherapy 2Psychiatric Rehabilitation 2Cyclophosphamide 2montanide ISA 51 1entinostat 1cediranib 1Trastuzumab 1Thiotepa 1Therapeutics 1Thalidomide 1SUB1 protein, human 1Peripheral Blood Stem Cell Transplantation 1Microscopy, Electron 1Melphalan 1Interleukin-2 1Gene Rearrangement 1Gene Expression Profiling 1Fluorodeoxyglucose F18 1Fentanyl 1FPP(RGD)2 1Etoposide 1Erlotinib Hydrochloride 1Early Intervention, Educational 1Docetaxel 1Cryosurgery 1Counseling 1Carmustine 1Carboplatin 1CYT-6091 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms, Male × Trastuzumab × Sarcoma × Clear all
NCT00433407 2012-10-04

T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors

Jonsson Comprehensive Cancer Center

Phase NA Completed
12 enrolled
BreastGenitourinaryGynecologicSarcomaThoracic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Breast Neoplasms, Male, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡